Immune to Cancer: The CRI Blog
-
CRI Funded Scientist
Yifat Merbl, PhD
Cellular proteasomes are considered the main compartment for protein degradation, and may be considered as the cellular… -
CRI Funded Scientist
Iliyan D. Iliev, PhD
Cancer is among the leading causes of death worldwide and host-bacterial microbiota immune interactions profoundly influence tumorigenesis,… -
CRI Funded Scientist
Matthew H. Spitzer, PhD
While much of cancer immunology focuses on the tumor environment itself—and rightly so—cancer also affects immune cells… -
CRI Funded Scientist
Kole T. Roybal, PhD
Engineered T cell therapies for cancer suffer from a spectrum of deficiencies in solid malignancies. These range… -
CRI Funded Scientist
Liang Chi, PhD
Sex differences in the immune system are associated with higher susceptibility to numerous infectious diseases and cancers… -
CRI Funded Scientist
Qiao Lu, PhD
As the self-derived “demon,” tumor cells can grow uncontrollably and actively suppress T cells, one of the… -
CRI Funded Scientist
Rui Miao, PhD
Cancer immunotherapy, which takes advantage of the patient’s own immune system to fight cancer, has achieved great… -
CRI Funded Scientist
Nadav Brandes, PhD
One of the most important breakthroughs in treating cancer has been the engineering of immune cells to… -
CRI Funded Scientist
Michelle L. Hess, PhD
Our immune system is designed to recognize and eliminate cancer cells through the same mechanisms as it…

Join CRI in Shaping the Future of Immunotherapy
Support the pioneering work of CRI in advancing immunotherapy.